Masimo Corporation (NASDAQ:MASI) Receives Average Rating of “Hold” from Analysts

Shares of Masimo Corporation (NASDAQ:MASI) have been assigned a consensus rating of “Hold” from the nine research firms that are currently covering the firm, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a hold recommendation. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $180.40.

A number of research firms recently weighed in on MASI. Raymond James Financial lowered shares of Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Finally, Wells Fargo & Company raised shares of Masimo to a “hold” rating in a research note on Wednesday, March 18th.

Masimo Stock Performance

NASDAQ MASI opened at $179.95 on Friday. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.45. Masimo has a 1-year low of $125.94 and a 1-year high of $179.99. The business has a 50 day simple moving average of $179.25 and a two-hundred day simple moving average of $165.98. The stock has a market capitalization of $9.42 billion, a PE ratio of -17.07, a P/E/G ratio of 1.82 and a beta of 1.11.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in MASI. Massachusetts Financial Services Co. MA lifted its stake in shares of Masimo by 1.7% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,663,875 shares of the medical equipment provider’s stock valued at $346,464,000 after purchasing an additional 43,915 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its position in shares of Masimo by 9.6% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,330,158 shares of the medical equipment provider’s stock valued at $303,061,000 after purchasing an additional 203,395 shares during the last quarter. Naya Capital Management UK Ltd. bought a new position in shares of Masimo during the 4th quarter valued at approximately $202,984,000. Westfield Capital Management Co. LP raised its holdings in Masimo by 7.2% during the 4th quarter. Westfield Capital Management Co. LP now owns 1,522,049 shares of the medical equipment provider’s stock valued at $197,958,000 after buying an additional 102,799 shares during the period. Finally, State Street Corp raised its holdings in Masimo by 0.7% during the 2nd quarter. State Street Corp now owns 1,486,394 shares of the medical equipment provider’s stock valued at $250,041,000 after buying an additional 10,403 shares during the period. Hedge funds and other institutional investors own 85.96% of the company’s stock.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.